| International Nonproprietary N |
Proposed INN List No. 125 | WHO Drug Information,2021,35,2 | 查看 |
| ATC/DDD Classification |
ATC/DDD Classification (Final) | WHO Drug Information,2021,35,2 | 查看 |
| ATC/DDD Classification |
ATC/DDD Classification (Temporary) | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
WHO/UNFPA Guidance on Natural Rubber Latex Condom Stability Studies | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
WHO Guidelines on the Transfer of Technology Pharmaceutical Manufacturing | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
Ulipristal acetate tablets (ulipristali acetas compressi) | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
Ulipristal acetate (ulipristali acetas) | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
Remdesivir intravenous infusion (remdesiviri infusio intraveno) | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
Remdesivir (remdesivirum) | WHO Drug Information,2021,35,2 | 查看 |
| Consultation Documents |
Linezolid (linezolidum) | WHO Drug Information,2021,35,2 | 查看 |
| International Nonproprietary N |
Recommended INN List No. 85 | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Good Manufacturing Practices for Medical Gases | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Inquiry regarding WHO product-specific guidance on the design of bioequivalence studies | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Guidance on setting remaining shelf life for the supply and procurement of emergency health kits | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Gelatin (gelatina) | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Ethanol, Anhydrous (ethanolum, anhydricum) | WHO Drug Information,2021,35,1 | 查看 |
| Consultation Documents |
Ethanol 96% (V/V) (ethanolum 96% (V/V)) | WHO Drug Information,2021,35,1 | 查看 |
| Regulatory News |
WHO Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce. Update for improving reliance and adaptation to the new pharmaceutical environment. | WHO Drug Information,2021,35,1 | 查看 |
| Regulatory News |
55th Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) meeting | WHO Drug Information,2021,35,1 | 查看 |
| International Nonproprietary N |
Proposed INN List No. 124 | WHO Drug Information,2020,34,4 | 查看 |
